Venous thromboembolic disease and cancer

25Citations
Citations of this article
48Readers
Mendeley users who have this article in their library.

Abstract

Venous thromboembolic disease is a common cause of mortality and morbidity in patients with cancer. Patients have a 5-6-fold increase in the risk for a venous thromboembolism (VTE) compared with the general population, increasing to 6-7-fold for some cancers. Prophylaxis for VTE should be considered whenever additional risk factors intervene. About 10% of patients with an idiopathic VTE will harbour an occult cancer. Half of these can probably be detected after a focused history, examination, routine blood tests and a chest x ray. The remaining cases may be diagnosed with an intensive screening protocol. About 60% of patients diagnosed on screening will have early disease, but we do not know whether screening improves the outcome. Evidence suggests that patients with cancer and a VTE should be treated with low-molecular-weight heparin, and treatment continued until the cancer is cured.

Cite

CITATION STYLE

APA

Fennerty, A. (2006, October). Venous thromboembolic disease and cancer. Postgraduate Medical Journal. https://doi.org/10.1136/pgmj.2006.046987

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free